---
title: "\"Performance\" Novosense's annual loss narrowed to 229 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281110360.md"
description: "Novosense announced its full-year results for the year ended December last year, with a revenue of RMB 3.368 billion, an increase of 71.8% year-on-year. The loss narrowed to RMB 229 million, compared to a loss of RMB 403 million in the same period last year; the loss per share was RMB 1.6. No dividend was declared"
datetime: "2026-03-31T02:03:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281110360.md)
  - [en](https://longbridge.com/en/news/281110360.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281110360.md)
---

# "Performance" Novosense's annual loss narrowed to 229 million yuan

Novosense (02676.HK) announced its full-year results for the year ended last December, with a revenue of RMB 3.368 billion, an increase of 71.8% year-on-year. The loss narrowed to RMB 229 million, compared to a loss of RMB 403 million in the same period last year; the loss per share was RMB 1.6. No dividend was declared

### Related Stocks

- [02676.HK](https://longbridge.com/en/quote/02676.HK.md)
- [688052.CN](https://longbridge.com/en/quote/688052.CN.md)

## Related News & Research

- [Suzhou Novosense Issues Unaudited First-Quarter 2026 Report Under PRC Standards](https://longbridge.com/en/news/284280968.md)
- [Rising Bond Yields Weigh on Stocks](https://longbridge.com/en/news/286939009.md)
- [BoE Gov. Bailey: We have a softening picture for growth and the labour market](https://longbridge.com/en/news/287076756.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Roger Stone allegedly threatened political retribution against Cuomo brothers, others in text messages](https://longbridge.com/en/news/286942036.md)